RIPE Knowledge Graph
RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1186%2Fs13063-025-08836-4

https://w3id.org/ripe/ripe-kg/work/10.1186%2Fs13063-025-08836-4
SubjectPredicateObject
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity ripe:concerns ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
ripekg:registry-evidence/RIPEABC7D27C0BF8128FA ripe:concerns ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
ripekg:research-integrity-assessment/RIPEABC7D27C0BF8128FA ripe:assesses ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
ripekg:study-design-evidence/RIPEABC7D27C0BF8128FA ripe:concerns ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity prism:doi 10.1186/s13063-025-08836-4
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity dcterms:creator ripekg:author/RIPEAU28FB7632E1F8EF95Jamshid Ahmadi
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity dcterms:creator ripekg:author/RIPEAU5673013E10206FBBArash Mansoori
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity dcterms:creator ripekg:author/RIPEAU9E25A6E9E30ADFEFSeyed Mosavat
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity dcterms:creator ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity dcterms:title Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/10.2217%2Fpgs-2020-0157Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/10.4088%2Fpcc.13r01621Pharmacologic treatment of dimensional anxious depression: a review
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW0230CB57A188D56ACo-occurring psychiatric and substance use disorders. pharmacotherapy for complex substance use disorders: a practical guide
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW05A0E46A39DFFA0EAntidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW11F2115022E24820Prevalence of comorbid anxiety disorders and their associated factors in patients with bipolar disorder or major depressive disorder
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW16B8B994D4D18271The efficacy of buprenorphine in major depression, treatment-resistant depression and suicidal behavior: a systematic review
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW1D9910F1A42BCC9CRisk of opioid overdose associated with concomitant use of oxycodone and selective serotonin reuptake inhibitors
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW1DDD009490B8133FKappa opioids, salvinorin A and major depressive disorder
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW214E5BF6F5652AA9Glutamatergic receptor and neuroplasticity in depression: implications for ketamine and rapastinel as the rapid-acting antidepressants
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW24DF139A971C5BD9The global gap in treatment coverage for major depressive disorder in 84 countries from 2000-2019: a systematic review and Bayesian metaregression analysis
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW262D9007FA9A1303The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW26C2DD5CABBBBAB9Dose-Related effects of adjunctive ketamine in taiwanese patients with treatment-resistant depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW2750C514F7B6633FDemystifying Buprenorphine with Current Evidence-Based Practice in Acute and Chronic Pain Management
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW27B2F08785ED6333Pharmacotherapeutic management of co-morbid alcohol and opioid use
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW28A28A96F5306487Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW2B1B668A642E2444The kappa opioid receptor: from addiction to depression, and back
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW2CAE679143EDFCA1The importance of buprenorphine research in the opioid crisis
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW2E72F2176C1A3783Ketamine's rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW2EE70D8BF52B6424Association of opioid misuse with anxiety and depression: a systematic review of the literature
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW319417ABBFCD7F20Ketamine for chronic depression: two cautionary tales
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW341DD8F8C208326CKetamine for treatment-resistant depression: when and where is it safe
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW38914A0055151155A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW3B3BB7F9877716D3Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW483245FBCD41EEEDThe role of craving in substance use disorders: theoretical and methodological issues
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW4DCBFFEA6EA57069Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW4E369C7E39ACFD0EMu opioid receptor-positive neurons in the dorsal raphe nucleus: role in reward. Emotional Responses and Morphine Abstinence
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW530D3175714F901CRapid-acting antidepressants: mechanistic insights and future directions
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW56015DA865D98DECBuprenorphine treatment for opioid use disorder: recent progress
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW5625F70662F527E5Buprenorphine pharmacodynamics and pharmacokinetics, Handbook of methadone prescribing and buprenorphine therapy
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW5A8BDA68275F89FFEfficacy of ketamine in the treatment of substance use disorders: a systematic review
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW5CFBD1B1EFFFB981Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW5F1132E75987B2A5Ketamine for the treatment of major depression: a systematic review and meta-analysis
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW61CFC85B9CFA5B70A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW6335AE3681723EC0Genomewide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW63BBEAA3590CBC12Health (care) in the crisis: reflections in science and society on opioid addiction
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW66B8CB4EA8B0B096Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and posttraumatic stress disorder in substance use disorders: a Bayesian metaanalysis
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW677139F510C4CBD3Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW6AA65BDBC06E8C58Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: a randomized, double blind, placebo-controlled study
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW6BF51A7C7AF3EEB6Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW8296D62AB3FEA34AAcute and sustained effects of cognitive emotion regulation in major depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW902289699A9B10A7Comparison of ketamine with buprenorphine as adjunctive therapy in the treatment of comorbid major depressive disorder and opium use disorders: a randomized controlled trial
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW911C6A5890CBF608Non-opioid treatments for opioid use disorder: rationales and data to date
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW95983BEBAFA34C95Sample size estimation in clinical research: from randomized controlled trials to observational studies
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEW96CDE40E5CC8AA4DBehavioral pharmacology of novel kappa opioid receptor antagonists in rats
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWA4AA221648122E83Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWAE86DF9C8FB558E9Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWAF0769D3DCB614B4The promise of ketamine for treatment-resistant depression: current evidence and future directions
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWB54517D6E9E23038Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWB568EA7BD497D16AAnxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWC0B7ABED2F29FF6DDifferences between ketamine's short-term and long-term effects on brain circuitry in depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWC34F54DC295E2675Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWC826466743F1361ASingle high-dose buprenorphine for opioid craving during withdrawal
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWC83A68404139DCCDDiagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWCBE839CE5B5FAB4BNew trends in personalized treatment of depression
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWD140ED0CC89BBFC3Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWD32331A3F6CE38FCPsychiatric comorbidities in patients with major depressive disorder
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWD5CCB5588A18EC7BOpioid use disorder
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWD8932542DABDDE75Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWDC5204A82F99654CThe neuroscience of drug reward and addiction
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWE121907E9AB494A1Pharmacogenomics: A road ahead for precision medicine in psychiatry
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWE17E055F64E53626Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: an in vivo electrophysiological study on monoaminergic and glutamatergic neurons
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWE4700B1DAF730CAFOpioid use disorder: current trends and potential treatments
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWEB7ABA56C11D7F29Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWED0C9FE79EDE3537Mechanisms underlying the anti-suicidal treatment potential of buprenorphine
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWF14B4679F28397CCDepressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWF57E3D9B1EB44566A review of ketamine abuse and diversion
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity http://purl.org/spar/cito/cites ripekg:work/RIPEWF69F851C064EF9B1Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity rdf:type node1
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity rdf:type rdfs:Resource
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity rdf:type owl:Thing
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity rdf:type prov:Entity
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity rdf:type ripe:WorkWork
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity owl:sameAs https://semopenalex.org/work/W4409526464